Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease

Details for Australian Patent Application No. 2006278713 (hide)

Owner Merck & Co., Inc.

Inventors Vacca, Joseph P.; Nantermet, Philippe G.

Agent Spruson & Ferguson

Pub. Number AU-A-2006278713

PCT Pub. Number WO2007/019111

Priority 60/705,075 03.08.05 US

Filing date 28 July 2006

Wipo publication date 15 February 2007

International Classifications

A61K 31/739 (2006.01) - Lipopolysaccharides

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019111 Priority application(s): WO2007/019111

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278714-Integrated three-port receptacle and method for connecting hand and foot switched electrosurgical accessories

2006278708-Fuel cell with fuel monitoring system and method of use